Randomised clinical trial: gabapentin vs baclofen in the treatment of suspected refractory gastro‐oesophageal reflux‐induced chronic cough
Alimentary Pharmacology & Therapeutics2019Vol. 49(6), pp. 714–722
Citations Over TimeTop 10% of 2019 papers
Ran Dong, Xianghuai Xu, Li Yu, Hongmei Ding, Jing Pan, Yiming Yu, Cuiqin Shi, Qiang Chen, Mengru Zhang, Hanjing Lv, Zhongmin Qiu
Abstract
Gabapentin and baclofen have similar therapeutic efficacy for suspected refractory gastro-oesophageal reflux-induced chronic cough. However, gabapentin may be preferable because of fewer side effects. Trial Register: http://www.chictr.org/; No.: ChiCTR-ONC-13003066.
Related Papers
- → A pharmacokinetic study comparing single and repeated oral doses of 20�mg and 40�mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects(2004)91 cited
- → Thrombocytopenia with gabapentin usage(2015)6 cited
- → Acid Inhibitory Potency of Twice a Day Omeprazole is not Affected by Eradication of Helicobacter pylori in Healthy Volunteers(2003)4 cited
- → Prediction of Therapeutic Doses Based on the Pharmacokinetic/Pharmacodynamic Model of Omeprazole, a Proton Pump Inhibitor.(1992)3 cited
- Omeprazole maintenance therapy prevents recurrent ulcer bleeding after surgery for duodenal ulcer(2006)